🔎 Trials Near Me

Inicio › Cáncer de pulmón › Distrito de Columbia

Ensayos clínicos de Cáncer de pulmón en Distrito de Columbia

27 estudios sobre Cáncer de pulmón buscan participantes en Distrito de Columbia.

Ciudades en Distrito de Columbia

Texto oficial del estudio (inglés)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • George Washington University Medical Center, Washington D.C.
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • George Washington University Medical Center, Washington D.C.
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT04181060

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Washington D.C.
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Georgetown University, Washington D.C.
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07154290

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Washington DC Veterans Affairs Medical Center, Washington D.C.
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06758401

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
  • MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • MedStar Georgetown University Hospital, Washington D.C.
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Georgetown University Lombardi Cancer Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Washington D.C.
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07038343

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Georgetown University Medical Center, Washington D.C.
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jun 2026 · NCT06162221

Gilteritinib for the Treatment of ALK NSCLC

  • Georgetown University, Washington D.C.
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 jun 2026 · NCT06225427

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • Georgetown University Medical Center, Washington D.C.
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT06922591

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 5 may 2026 · NCT06031688

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 abr 2026 · NCT02333604

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Sibley Memorial Hospital, Washington D.C.
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT06810544

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

  • The George Washington University Hospital, Washington D.C.
ReclutandoFase 3
Edades de 18 a 90 · Todos los sexos · Actualizado el 9 abr 2026 · NCT06810375

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
  • Medstar Washington Hospital Center, Washington D.C.
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 mar 2026 · NCT04499053

Erector Spinae Block for Thoracic Surgery

  • The George Washington University, Washington D.C.
ReclutandoFase 4
Edades de 18 a 90 · Todos los sexos · Actualizado el 25 feb 2026 · NCT05521789

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • MedStar Georgetown University Hospital, Washington D.C.
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT06073431

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The George Washington University Cancer Center (site 212), Washington D.C.
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

  • MedStar Health, Washington D.C.
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 27 dic 2024 · NCT04675476

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.